落实《药品不良反应报告和监测管理办法》浅议  

Discussion on How to Execute the Practice of Reporting and Supervision of ADR

作　　者：张万新 

机构地区：[1]湖南省长沙市食品药品监督管理局,长沙410005

出　　处：《中国药事》2012年第2期157-158,共2页Chinese Pharmaceutical Affairs

摘　　要：目的推进药品不良反应报告和监测管理工作顺利开展。方法梳理药品不良反应报告和监测管理工作实践,分析存在的问题。结果与结论药品不良反应报告和监测管理工作仍然存在一些尚待完善之处,笔者就此提出了一些具体的建议。Objective To carry out the works of monitoring and reporting of ADRs effectively. Methods Analyze and summarize existing problems on the current status of supervision and reporting of ADR. Results and Conclusion There were still many problems existing in current reporting of ADR and supervision. Some personal opinions and suggestions on how to solve those problems were presented in this article.

关 键 词：药品不良反应 报告 监测 

分 类 号：R95[医药卫生—药学]